INFECTIOUS DISEASE

Novavax's COVID-19 vaccine was granted emergency use authorization by the FDA on Wednesday, setting it up to be a fourth vaccine option for Americans.

A former Colorado funeral home owner pleaded guilty to fraud after she sold body parts of the deceased without receiving consent from their families.

CureVac is suing Pfizer's German partner BioNTech for alleged patent infringement related to the development of their mRNA vaccines against COVID-19.

Britain's Oxford Biomedica announced an agreement to potentially make AstraZeneca's COVID-19 vaccine beyond 2022. It has already manufactured more than 100 million doses since 2020.

BioNTech, Pfizer's Germany-based partner in COVID-19 vaccines, said the two companies would start tests on humans of next-generation coronavirus vaccines.

The FDA will decide on whether changes are needed to the COVID vaccines in order to keep up with recent coronavirus variant by early July.

Publix will not be offering COVID-19 vaccines to children younger than 5, a spokesperson for the supermarket chain told Fox 13 Tampa Bay on Wednesday.

According to the White House's COVID-19 response coordinator Dr. Ashish Jha, the U.S has begun distributing COVID-19 vaccines for children as young as six months.

Pfizer agreed to invest $95.24 million to buy an 8% percent stake in French vaccine company Valneva as the two companies work to stop Lyme disease.

Pfizer and Moderna's vaccines for children as young as 6 months old could be available next week after an FDA advisory panel recommended them on Wednesday.

The FDA's advisory committee on vaccines unanimously recommended Moderna's COVID-19 vaccine for kids between the ages of 6 and 17 on Tuesday.

The FDA said Pfizer's coronavirus vaccine appears to be safe for children younger than 5, the only age group not yet eligible for vaccination in the U.S.

A panel of vaccine experts recommended Novavax's COVID-19 vaccine for emergency use authorization on Tuesday, potentially paving the way for a fourth vaccine option.

Pfizer asked the Food and Drug Administration on Wednesday authorize three doses of their COVID-19 vaccine for children younger than 5 years old.

The FDA revised its emergency authorization to sharply limit the use of Johnson & Johnson's COVID-19 vaccine due to a rare but potentially fatal blood clotting condition called thrombosis with thrombocytopenia syndrome (TTS).